Rejected at 2:30 a.m. Feb, 21, 2024 ] by herstein.jacob
Author: adityatadanki
Related Note: 1481857931212 1
Rationale for change

Page 536 of the 2023 edition of First Aid mentions that symptoms of Huntington Disease begin at 30 years age, NOT 20 years age. (Older editions of First Aid said 30 years)

Symptoms typically manifest between age 30 and 50: chorea, athetosis, aggression, depression, dementia (sometimes initially mistaken for substance use).

Rejection reason

AMBOSS says 20-50, probably better to have more inclusive range than more restricted range. https://next.amboss.com/us/article/y30dOf?q=huntington%20disease

Text Text
Extra
Empty field
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid

Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Physeo

OME

Additional Resources
Atlas:



One by one
Empty field
#AK_Step1_v12::#SketchyPath::13_Neuro::05_Neurodegenerative::02_Creutzfeldt-Jakob_Disease,_Parkinsons_Disease_&_Huntingtons_Disease #AK_Step1_v12::#Physeo::^physeo_image_update !AK_UpdateTags::Step1decks::Zanki-Step-Decks::Zanki-Neurology::Neuro-Pathology #AK_Step1_v12::#AMBOSS::32aShP #AK_Step2_v12::#Resources_by_rotation::Neuro::uw::zanki #AK_Step2_v12::#B&B::10_Neuro::03_Movement_Disorders::02_Movement_Disorders #AK_Step2_v12::#NBME #AK_Step1_v12::#Pathoma::17_Neuro::07_Dementia_&_Degenerative_Disorders #AK_Step2_v12::#AMBOSS::zv0rcR #AK_Step1_v12::#Pixorize::05_Neuroanatomy::14_Neurological_Disorders::03_Huntington_Disease #AK_Step1_v12::#FirstAid::12_Neurology_and_Special_Senses::03_Pathology::19_Neurodegenerative_movement_disorders::*Huntington_Disease #AK_Step1_v12::#UWorld::COMLEX::26241 #AK_Step2_v12::!Shelf::Neuro::no_dupes #AK_Step1_v12::#UWorld::Step::15328 #AK_Step2_v12::Original_decks::Zanki_Step_2::Neuro::UW_Neuro #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Neurology::Neuro_Pathology #AK_Step1_v12::#Physeo::05_Biochem::04_Genetics::13_Trinucleotide_Repeat_Disorders_-_Huntington_Disease #AK_Step1_v12::#B&B::10_Genetics::02_Genetic_Disorders::04_Trinucleotide_Repeat_Disorders::Extra #AK_Step1_v12::#Bootcamp::Genetics::07_High_yield_genetic_disorders::04_Trinucleotide_Repeat_Expansion_Diseases #AK_Step1_v12::#Bootcamp::Neurology::26_Dementia::07_Additional_Causes_of_Dementia #AK_Step1_v12::#FirstAid::01_Biochem::04_Genetics::14_Trinucleotide_repeat_expansion_diseases::*Huntingon #AK_Step1_v12::#B&B::15_Neuro::07_Other_Neurology_Topics::08_Parkinson's_Huntington's_and_Movement_Disorders #AK_Step1_v12::^Other::^HighYield::3-HighYield-temporary #AK_Step2_v12::#AMBOSS::7M04Jg #AK_Step1_v12::#Physeo::11_Pathology::05_Neuropathology_Pathology::05_Dementia_Degenerative_Disorders #AK_Step1_v12::^Systems::Neuro::Pathology #AK_Step1_v12::#OME_banner::Basic_Science::03_Genetics